Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties

被引:23
作者
Congiu, Cenzo [1 ]
Onnis, Valentina [1 ]
Balboni, Gianfranco [1 ]
Supuran, Claudiu T. [2 ,3 ]
机构
[1] Univ Cagliari, Dept Life & Environm Sci, I-09124 Cagliari, Italy
[2] Univ Firenze, Lab Chim Bioinorgan, I-50019 Florence, Italy
[3] Univ Firenze, Dipartimento NEIROFABA, Sez Sci Farmaceut & Nutraceut, I-50019 Florence, Italy
关键词
Carbonic anhydrase; Isoforms I; II; IX; XII; Sulfonamide; Sulfanilamide; Tumor-associated enzymes; AROMATIC/HETEROCYCLIC SULFONAMIDES; BENZENE SULFONAMIDES; CYANAMIDE HYDRATION; TRYPANOSOMA-CRUZI; POTENT INHIBITORS; ANION INHIBITION; CAUSATIVE AGENT; PATENT; ALPHA; BETA;
D O I
10.1016/j.bmcl.2014.02.030
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of sulfonamides incorporating the sulfanilamide ( SA) scaffold were prepared. Reaction of the 4-amino moiety of SA with benzyl chlorides or substituted bromoacetophenones afforded the derivatives which were then reacted with 1,1,1-trifluoro-4-isobutoxybut-3-en-2-one leading to a series of 4-N,N-disubstituted SAs. The key intermediates were also reacted with ethoxycarbonyl isothiocyanate leading to thioureas or were cyclized in the presence of potassium cyanate/isothiocyanate to the corresponding imidazol-2(3H)-one/thiones. The new compounds were tested as inhibitors of four carbonic anhydrase (CA, EC 4.2.1.1) isoforms, the cytosolic CA I and II, and the transmembrane, tumor-associated CA IX and XII. These sulfonamides were ineffective CA I and II inhibitors but were nanomolar CA IX and XII inhibitors, making them of interest as clinical candidates for antitumor/antimetastasis applications. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1776 / 1779
页数:4
相关论文
共 59 条
  • [1] Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review
    Aggarwal, Mayank
    Kondeti, Bhargav
    McKenna, Robert
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (06) : 717 - 724
  • [2] Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties
    Alafeefy, Ahmed M.
    Abdel-Aziz, Hatem A.
    Vullo, Daniela
    Al-Tamimi, Abdul-Malek S.
    Al-Jaber, Nabila A.
    Capasso, Clemente
    Supuran, Claudiu T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (01) : 141 - 147
  • [3] Carbonic anhydrase inhibitors: Benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII
    Alafeefy, Ahmed M.
    Isik, Semra
    Abdel-Aziz, Hatem A.
    Ashour, Abdelkader E.
    Vullo, Daniela
    Al-Jaber, Nabila A.
    Supuran, Claudiu T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1396 - 1403
  • [4] Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI
    Alp, Cemalettin
    Ozsoy, Seyda
    Alp, Nurdan Alcan
    Erdem, Deryanur
    Gultekin, Mehmet Serdar
    Kufrevioglu, Omer Irfan
    Senturk, Murat
    Supuran, Claudiu T.
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (06) : 818 - 824
  • [5] Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
    Alterio, Vincenzo
    Di Fiore, Anna
    D'Ambrosio, Katia
    Supuran, Claudiu T.
    De Simone, Giuseppina
    [J]. CHEMICAL REVIEWS, 2012, 112 (08) : 4421 - 4468
  • [6] REDUCTION OF SCHIFF BASES .3. REDUCTION WITH DIMETHYLAMINE BORANE
    BILLMAN, JH
    MCDOWELL, JW
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1961, 26 (05) : 1437 - &
  • [7] Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms
    Biswas, Shyamasri
    Aggarwal, Mayank
    Guezel, Ozlen
    Scozzafava, Andrea
    McKenna, Robert
    Supuran, Claudiu T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (12) : 3732 - 3738
  • [8] Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking the physiological reaction?
    Briganti, F
    Mangani, S
    Scozzafava, A
    Vernaglione, G
    Supuran, CT
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 1999, 4 (05): : 528 - 536
  • [9] Carbonic anhydrase inhibitors .37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes
    Briganti, F
    Pierattelli, R
    Scozzafava, A
    Supuran, CT
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (12) : 1001 - 1010
  • [10] Anti-infective carbonic anhydrase inhibitors: a patent and literature review
    Capasso, Clemente
    Supuran, Claudiu T.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (06) : 693 - 704